Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential

Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06515860	Neurofibromatosis Type 1 Tumor Early Detection Study(NF1-TED)	enrolling by invitation	—	1,000	David MillerOTHER	1	Aug 31, 2026	clinicaltrials
NCT06735820	Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST(MEKMDM2)	recruiting	Phase 1 / Phase 2	45	AeRang KimOTHER	1	Jul 27, 2026	clinicaltrials
NCT05677594	Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1	active not recruiting	—	80	Johns Hopkins UniversityOTHER	1	Jan 12, 2026	clinicaltrials
NCT03820778

Data updated 22 days agoSource updated Aug 31, 2026source: clinicaltrials